FMS-like tyrosine kinase 3acute myeloid leukemiaosteosarcomaMolecular targeted therapy is a type of cancer treatment which attempts to interfere with specific molecules involved in the growth of cancer. Several drugs have been approved for certain types of cancer, including breast cancer, colon cancer,...
ALW-II-41-27是一种新颖的Eph receptor抑制剂,用于癌症研究。 注:本品仅可用于科研实验,严禁用于临床医疗及其他用途! CAS号:1186206-79-0 别名:Eph receptor tyrosine kinase inhibitor 纯度:99.59% 分子式:C??H??F?N?O?S 分子量:607.69 结构式: ...
ALW-II-41-27是一种新颖的Eph receptor抑制剂,用于癌症研究。 注:本品仅可用于科研实验,严禁用于临床医疗及其他用途! CAS号:1186206-79-0 别名:Eph receptor tyrosine kinase inhibitor 纯度:99.59% 分子式:C₃₂H₃₂F₃N₅O₂S 分子量:607.69 结构式: 储存条件:-20℃,有效期2年,溶入溶剂后-...
9.The Effects of Combined Administration of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Cytotoxic Drugs in Different Tumor Cell Lines表皮生长因子受体酪氨酸激酶抑制剂联合化疗对不同肿瘤细胞株的作用 10.Project Epidermal Growth Factor Receptor Tyrosine Protein Kinase Inhibitor Screen Model;...
Erlotinib: An EGF Receptor Tyrosine Kinase Inhibitor in Non-small-cell Lung Cancer Treatment Expert Commentary The EGFR is an excellent target for novel therapeutic agents for the treatment of several epithelial malignancies. The major challenge for an optimal use of EGFR-targeting drugs is to ...
英文名字 Receptor Tyrosine Kinase (RTK) Inhibitor Set, DiscoveryPak 供应商 BioVision 产品货号 K859-8 产品报价 ￥已停产 产品说明书 点击查看 购买方式 银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868. 产品新闻 ...
The common activation of ALK has led to the use of the ALK tyrosine kinase inhibitor (TKI) crizotinib in a range of patient populations and to the rapid development of second-generation drugs targeting ALK. In this Review, we discuss our current understanding of ALK function in human cancer ...
Sunitinib malate, 98%, a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively品牌: J&K 产品编号: 1020808 CAS: 341031-54-7 分子式: C22H27FN4O2·C4H6O5 分子量: 532.56 纯度: 98%...
receptor tyrosine kinases, they testeddrugs targetingTK that may protect SCs from apoptosis in vitro. As a result,dasatinib(D) showed particular promise in clearing SCs. D is an potent inhibitor of multiple TK, used for treating tumors (Montero et al., 2011), and is known to interfere with...
1. Objective To explore the protective role of the receptor tyrosine kinase inhibitor in chondrocyte in vitro. 目的通过对体外培养软骨细胞的实验研究,探寻受体酪氨酸激酶抑制剂对软骨细胞在细胞分子水平的影响及其可能机制。更多例句>> 2) RTK inhibitors 酪氨酸激酶受体抑制剂...